Abstract
Transplantation of human fetal neural tissue into adult neostriatum is an experimental therapy for Huntington’s disease (HD). Here we describe a patient with HD who received ten intrastriatal human fetal neural transplants and, at one site, an autologous sural nerve co-graft. Although initially clinically stable, she developed worsening asymmetric upper motor neuron symptoms in addition to progression of HD, and ultimately died 121 months post transplantation. Eight neural transplants, up to 2.9 cm, and three ependymal cysts, up to 2.0 cm, were identified. The autologous sural nerve co-graft was found adjacent to the largest mass lesion, which, along with the ependymal cyst, exhibited pronounced mass effect on the internal capsules bilaterally. Grafts were composed of neurons and glia embedded in disorganized neuropil; robust Y chromosome labeling was present in a subset of grafts and cysts. The graft–host border was discrete, and there was no evidence of graft rejection or HD pathologic changes within donor neurons. This report, for the first time, highlights the potential for graft overgrowth in a patient receiving fetal neural transplantation.
References
Bachoud-Lévi A, Bourdet C, Brugières P, Nguyen JP, Grandmougin T, Haddad B, Jény R, Bartolomeo P, Boissé MF, Barba GD, Degos JD, Ergis AM, Lefaucheur JP, Lisovoski F, Pailhous E, Rémy P, Palfi S, Defer GL, Cesaro P, Hantraye P, Peschanski M (2000) Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington’s disease. Exp Neurol 161:194–202. doi:10.1006/exnr.1999.7239
Bachoud-Lévi AC, Gaura V, Brugières P, Lefaucheur JP, Boissé MF, Maison P, Baudic S, Ribeiro MJ, Bourdet C, Remy P, Cesaro P, Hantraye P, Peschanski M (2006) Effect of fetal neural transplants in patients with Huntington’s disease 6 years after surgery: a long-term follow-up study. Lancet Neurol 5:303–309. doi:10.1016/S1474-4422(06)70381-7
Bachoud-Lévi AC, Rémy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C, Baudic S, Gaura V, Maison P, Haddad B, Boissé MF, Grandmougin T, Jény R, Bartolomeo P, Dalla Barba G, Degos JD, Lisovoski F, Ergis AM, Pailhous E, Cesaro P, Hantraye P, Peschanski M (2000) Motor and cognitive improvements in patients with Huntington’s disease after neural transplantation. Lancet 356:1975–1979. doi:10.1016/S0140-6736(00)03310-9
Collier TJ, Elsworth JD, Taylor JR, Sladek JR Jr, Roth RH, Redmond DE Jr (1994) Peripheral nerve-dopamine neuron co-grafts in MPTP-treated monkeys: augmentation of tyrosine hydroxylase-positive fiber staining and dopamine content in host systems. Neuroscience 61:875–879. doi:10.1016/0306-4522(94)90410-3
Dunnett SB, Rosser AE (2007) Cell transplantation for Huntington’s disease: should we continue? Brain Res Bull 72:132–147. doi:10.1016/j.brainresbull.2006.10.019
Folkerth RD, Durso R (1996) Survival and proliferation of non-neural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology 46:1219–1225
Freeman TB, Cicchetti F, Hauser RA, Deacon TW, Li XJ, Hersch SM, Nauert GM, Sanberg PR, Kordower JH, Saporta S, Isacson O (2000) Transplanted fetal striatum in Huntington’s disease: phenotypic development and lack of pathology. Proc Natl Acad Sci USA 97:13877–13882. doi:10.1073/pnas.97.25.13877
Hauser RA, Furtado S, Cimino CR, Delgado H, Eichler S, Schwartz S, Scott D, Nauert GM, Soety E, Sossi V, Holt DA, Sanberg PR, Stoessl AJ, Freeman TB (2002) Bilateral human fetal striatal transplantation in Huntington’s disease. Neurology 58:687–695
Keene CD, Sonnen JA, Swanson PD, Kopyov O, Leverenz JB, Bird TD, Montine TJ (2007) Neural transplantation in Huntington’s disease: long-term grafts in two patients. Neurology 68:2093–2098. doi:10.1212/01.wnl.0000264504.14301.f5
Kopyov OV, Jacques S, Lieberman A, Duma CM, Eagle KS (1998) Safety of intrastriatal neurotransplantation for Huntington’s disease patients. Exp Neurol 149:97–108. doi:10.1006/exnr.1997.6685
Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat Med 14:504–506. doi:10.1038/nm1747
Kordower JH, Freeman TB, Bakay RA, Goetz CG, Olanow CW (1997) Treatment with fetal allografts. Neurology 48:1737–1738
Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P (2008) Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease progression. Nat Med 14:501–503. doi:10.1038/nm1746
Madrazo I, Franco-Bourland RE, Castrejon H, Cuevas C, Ostrosky-Solis F (1995) Fetal striatal homotransplantation for Huntington’s disease: first two case reports. Neurol Res 17:312–315
Mamelak AN, Eggerding FA, Oh DS, Wilson E, Davis RL, Spitzer R, Hay JA, Caton WL 3rd (1998) Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson’s disease. J Neurosurg 89:592–598
Mendez I, Sanchez-Pernaute R, Cooper O, Viñuela A, Ferrari D, Björklund L, Dagher A, Isacson O (2005) Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson’s disease. Brain 128:1498–1510. doi:10.1093/brain/awh510
Mendez I, Vinuela A, Astradsson A, Mukhida K, Hallett P, Robertson H, Tierney T, Holness R, Dagher A, Trojanowski JQ, Isacson O (2008) Dopamine neurons implanted into people with Parkinson’s disease survive without pathology for 14 years. Nat Med 14:507–509. doi:10.1038/nm1752
Peschanski M, Cesaro P, Hantraye P (1995) Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington’s disease. Neuroscience 68:73–285. doi:10.1016/0306-4522(95)00162-C
Peschanski M, Cesaro P, Hantraye P (1996) What is needed versus what would be interesting to know before undertaking neural transplantation in patients with Huntington’s disease. Neuroscience 71:899–900. doi:10.1016/0306-4522(95)00575-7
Quinn N, Brown R, Craufurd D, Goldman S, Hodges J, Kieburtz K, Lindvall O, MacMillan J, Roos R (1996) Core assessment program for intracerebral transplantation in Huntington’s disease (CAPIT-HD). Mov Disord 11:143–150. doi:10.1002/mds.870110202
Ross BD, Hoang TO, Blüml S, Dubowitz D, Kopyov OV, Jacques DB, Lin A, Seymour K, Tan J (1999) In vivo magnetic resonance spectroscopy of human fetal neural transplants. NMR Biomed 12:221–236. doi:10.1002/(SICI)1099-1492(199906)12:4<221::AID-NBM582>3.0.CO;2-Q
Rosser AE, Barker RA, Harrower T, Watts C, Farrington M, Ho AK, Burnstein RM, Menon DK, Gillard JH, Pickard J, Dunnett SB, NEST-UK (2002) Unilateral transplantation of human primary fetal tissue in four patients with Huntington’s disease: NEST-UK safety report ISRCTN no 36485475. J Neurol Neurosurg Psychiatry 73:678–685. doi:10.1136/jnnp.73.6.678
Sramka M, Rattaj M, Molina H, Vojtassák J, Belan V, Ruzický E (1992) Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington’s chorea. Stereotact Funct Neurosurg 58:79–83. doi:10.1159/000098976
Ulrisch R, Jacques S, Kopyov O (2000) Neural transplantation. J Neurosurg 93:163–164
Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44:559–577. doi:10.1097/00005072-198511000-00003
Watts RL, Mandir AS, Bakay RA (1995) Intrastriatal cografts of autologous adrenal medulla and sural nerve in MPTP-induced parkinsonian macaques: behavioral and anatomical assessment. Cell Transplant 4:27–38. doi:10.1016/0963-6897(95)92155-R
Watts RL, Subramanian T, Freeman A, Goetz CG, Penn RD, Stebbins GT, Kordower JH, Bakay RA (1997) Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson’s disease: two-year follow-up study. Exp Neurol 147:510–517. doi:10.1006/exnr.1997.6626
Acknowledgments
The authors wish to thank Randi Small, Regina Bowman, Susan Rozell, Christiane Ullness, Lynne Greenup, Aimee Schantz, Chiyen Miller, and Mike Hobbs for expert technical support. We would also like to thank Dr. Michael Laflamme for helpful discussions. This research was supported by National Institutes of Health grants P50-AG005136 and 5T32-AG000238, Veterans Affairs research funds, the University of Washington Huntington’s Disease Society of America Center of Excellence, and the Nancy and Buster Alvord Endowment.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keene, C.D., Chang, R.C., Leverenz, J.B. et al. A patient with Huntington’s disease and long-surviving fetal neural transplants that developed mass lesions. Acta Neuropathol 117, 329–338 (2009). https://doi.org/10.1007/s00401-008-0465-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-008-0465-0